A new immunotherapy treatment has been recommended by the National Institute for Health and Care Excellence (NICE) for some adults with small cell lung cancer.
A new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma has not been recommended for NHS use in England.
New ‘chemotherapy-free’ treatment for follicular lymphoma approved for NHS use in England.
A new kidney cancer drug combination of pembrolizumab with axitinib gets an initial no for the NHS in England
An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).
An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.
Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.
Patients in England with a certain type of advanced breast cancer will not have access to a new drug comb, after it was given an initial no for NHS use.
Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.
A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery.